J7527 HCPCS code: Everolimus, oral, 0.25 mg
J7527 is the HCPCS Level II code for everolimus, oral, 0.25 mg. In 2024 Medicare paid an average of $1.89 per service for J7527 across 5,218,143 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 960 per day on DME suppliers. Medicare volume fell 6% from 2022 to 2024 (5,559,833 to 5,218,143 services). In 2024, 999 suppliers billed Medicare for J7527 (purchases), serving 2,517 beneficiaries; California, Florida, Ohio accounted for 27% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1G — Immunizations/vaccinations |
| Added | 2013-01-01 |
| Last action effective | 2014-01-01 |
Who bills J7527 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 999 |
| Referring clinicians | 1,599 |
| Medicare beneficiaries | 2,517 |
| States with claims | 49 |
| Share of services in top 3 states (California, Florida, Ohio) | 27% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 1,019 | 2,471 |
| 2023 | 1,045 | 2,489 |
| 2024 | 999 | 2,517 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7527, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 5,559,833 | 2,471 | $5.05 | $3.92 |
| 2023 | 5,344,466 | 2,489 | $3.20 | $2.47 |
| 2024 | 5,218,143 | 2,517 | $2.46 | $1.89 |
States with the most J7527 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 570,269 | $1.91 |
| Florida | 449,114 | $1.90 |
| Ohio | 408,239 | $1.90 |
| Texas | 300,376 | $1.87 |
| New York | 299,726 | $1.90 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 960 | Clinical: Data |
| outpatient hospital claims | 40 | Prescribing Information |
| practitioner claims | 40 | Prescribing Information |
What changed for J7527
- 2013-01-01: J7527 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7527?
J7527 is the HCPCS Level II code for everolimus, oral, 0.25 mg. Short descriptor: "Oral everolimus".
How much does Medicare pay for J7527?
In 2024, the average Medicare payment was $1.89 per service (average allowed $2.46).
Does Medicare cover J7527?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J7527 can be billed per day?
960 on DME suppliers; 40 on outpatient hospital claims; 40 on practitioner claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7502 — Cyclosporine, oral, 100 mg
- J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7507 — Tacrolimus, immediate release, oral, 1 mg
- J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7510 — Prednisolone oral, per 5 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7527
- Watch J7527 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7527
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.